EPISODE · Aug 19, 2024 · 30 MIN
Ketamine Therapy for Treatment-Resistant Depression w/Dr. Irfan Fauq
from Mental Health Today Show | Anxiety Coping Skills & Mental Wellness · host John Cordray, LPC | Overthinking & Mental Wellness Expert
In this episode of Mental Health Today Show, Dr. Irfan Fauq dives deep into ketamine therapy as a groundbreaking treatment for treatment-resistant depression. Discover evidence-based insights into mental health coping strategies, anxiety management, and executive burnout relief. This conversation explores innovative therapeutic techniques and emotional resilience skills to help listeners manage stress and improve overall wellness.The value of intramuscular ketamine for treatment-resistant depression at Sierra Tucson: novel therapeutics for PTSD and psychosomatics.Psychiatrist, Director of Ketamine ServicesBorn in Pakistan, Dr. Irfan Fauq has served as a clinical assistant professor at the University of Arizona's College of Medicine in Psychiatry and now heads ketamine services at the mental health treatment center Sierra Tucson.He's been involved in the development of novel antipsychotics, and now coordinates the use (often at no cost) of intramuscular ketamine at Sierra Tucson.Learn more at https://www.sierratucson.comhttps://psychiatry.arizona.edu/profile/irfan-fauq-mdwww.mentalhealthtodayshow.comHost, John Cordray, LPC johncordraylpc.comReady for weekly tips to quiet overthinking and reclaim mental freedom? Subscribe to The Mental Freedom newsletter, actionable insights delivered for high achievers and overthinkers. Sign up here: https://johncordray.me/subscribe From John Cordray, LPC – Creator of MyndStill app @JohnCordrayLPC on X/LinkedIn Informational support only—not a substitute for professional therapy.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Ketamine Therapy for Treatment-Resistant Depression w/Dr. Irfan Fauq
No transcript for this episode yet
Similar Episodes
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m
Nov 12, 2025 ·35m
Oct 17, 2025 ·40m